Inflexion acquires German medical manufacturer Primed Group to scale global healthcare footprint

European private equity firm Inflexion has agreed to acquire German medical consumables manufacturer and sterilization provider Primed Group from Paragon Partners. The transaction, executed through Inflexion's Buyout Fund VI, marks the firm's sixth investment in the DACH region and aims to accelerate international commercial expansion.

According to official disclosures, European mid-market private equity firm Inflexion has agreed to acquire Primed Group from Paragon Partners. Financed through Inflexion's Buyout Fund VI, this transaction represents the firm's sixth investment within the DACH region. Headquartered in Germany, Primed Group is a vertically integrated manufacturer of certified single-use medical consumables and operates one of Europe's largest medical sterilization platforms.

The buyout is designed to scale the target company amid rising global market demand for single-use clinical supplies. To guide this growth strategy, healthcare industry veterans Wolfgang Suessle and Justin Barnes will join the board of directors, bringing extensive commercial and operational leadership to the business.

As regulatory requirements for medical devices tighten across Europe, well-capitalized, certified suppliers are increasingly vital to healthcare infrastructure. Inflexion's backing will fund accelerated product development and capacity expansions, securing supply chains for medical facilities across the 70 countries currently served by the platform.

For institutional investors, the transaction underscores the robust investment appetite for defensive healthcare assets in Western Europe. Moving forward, the enterprise plans to pursue an international growth strategy powered by strategic bolt-on acquisitions and expanded direct-to-market customer channels.